Scholars Central

Conference abstractPublished 5 Oct 2017

Lessons learned in a third-level hospital on the treatment of retinoblastoma

Authors: María de Spengler

Panama Children’s Hospital, Panama

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Introduction & Purpose: Everyday this tumor typical of early infancy has better results in terms of long-term survival. For the authors, treating retinoblastoma is an open book. Retinoblastoma is a pathology that requires a multidisciplinary approach. We still have a lot to learn. We want to share with the primary care pediatrician some important facts about retinoblastoma. Material & Methods: This is a descriptive, retrospective, transversal and single institution study that includes all retinoblastoma patients, diagnosed between the first of January 1996 and December 31, 2016. All the participants must have finished treatment at the moment of data collection (January 2017) and must be active in the follow-up clinic. Those patients that were missing from the follow-up for more than a year were excluded. Result: The age range at diagnosis is between 3 and 70 months. The average age at diagnosis is 21.3 months. One patient in our series had Wolf-Hirschhorn Syndrome. 68.4% of our cases received chemotherapy and 41% received chemo and radiation therapy. An attempt was made to preserve the eye in 26.3% of cases. What gave the indication to proceed with enucleation was retinal detachment in 66.6% of the cases, progression of the disease in the remaining 33.3%. In the series there is a percentage of 80.6% of patients who are alive and free of disease. Of the 25 patients who were alive at their last appointment, 42.1% had 10 or more years of survival. Of the survivors, 85.7% have completed their education. Conclusion: Today we have a great challenge to contribute to the quality of life of the survivors of childhood cancer. As a society we must create the best conditions for inclusion.

Subjects

Haematology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Leukemia.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Leukemia
  • SubjectHaematology
  • BylineArticles whose byline prints “María de Spengler”